RGD Reference Report - CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia? - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?

Authors: Turkmen, IC  Bassullu, N  Uraz, S  Yerdel, MA  Memisoglu, R  Bulbul Dogusoy, G 
Citation: Turkmen IC, etal., Turk Patoloji Derg. 2012;28(3):251-8. doi: 10.5146/tjpath.2012.01132.
RGD ID: 7349348
Pubmed: PMID:23011828   (View Abstract at PubMed)
DOI: DOI:10.5146/tjpath.2012.01132   (Journal Full-text)

OBJECTIVE: The description of Barrett's esophagus which is a risk factor for esophageal adenocarcinoma has differences, and the need of goblet cells for diagnosis is controversial. However, the pathophysiology in the metaplasia seen in Barrett's esophagus is not totally understood and new methods are searched for the assessment of progression to dysplasia. We aimed to search the immunohistochemical expression of CDX2, COX2 and MUC2 in Barrett's esophagus to detect any early evidence of intestinal metaplasia or dysplasia. MATERIAL AND METHOD: The staining properties were examined in the intestinal metaplastic (goblet cell-containing columnar epithelium), columnar (non-goblet columnar epithelium), distant columnar (non-goblet columnar epithelium distant from intestinal metaplastic epithelium) and squamous epithelium in 59 pathologically diagnosed Barrett's esophagus, 22 of which having dysplasia. The results were compared statistically with Pearson and Fisher exact tests. RESULTS: The distribution of the staining of intestinal metaplastic, non-goblet columnar distant columnar, and squamous epithelium, respectively were as follows: for CDX2 76.3%, 23.7%, 1.7%, 0%; for COX-2 93.2%, 47.5%, 8%, 62.9%; for MUC2 93.2%, 11.9%, 4% and 0%. The expression of CDX2, COX2 and MUC2 in the intestinal metaplastic epithelium was higher than the expression in distant and non-goblet columnar epithelium. The expression of CDX2, COX2 and MUC2 in the foci of dysplasia decreased significantly (18.2%, 27.3%, 31.9%, and p=0.039, 0.0001, 0.0001, respectively). COX2 expression in squamous epithelium was also lower when the adjacent mucosa has dysplasia (p=0.014). CONCLUSION: The CDX2, COX2 and MUC2 expressions were seen in the intestinal epithelium having goblet cells. The use of the markers in the diagnosis is controversial but the difference in the Barrett esophagus-dysplasia sequence seems to be meaningful.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
CDX2HumanBarrett's esophagus disease_progressionIEP  RGD 
Cdx2RatBarrett's esophagus disease_progressionISOCDX2 (Homo sapiens) RGD 
Cdx2MouseBarrett's esophagus disease_progressionISOCDX2 (Homo sapiens) RGD 
MUC2HumanBarrett's esophagus disease_progressionIEP  RGD 
Muc2RatBarrett's esophagus disease_progressionISOMUC2 (Homo sapiens) RGD 
Muc2MouseBarrett's esophagus disease_progressionISOMUC2 (Homo sapiens) RGD 
PTGS2HumanBarrett's esophagus disease_progressionIEP  RGD 
Ptgs2RatBarrett's esophagus disease_progressionISOPTGS2 (Homo sapiens) RGD 
Ptgs2MouseBarrett's esophagus disease_progressionISOPTGS2 (Homo sapiens) RGD 

Objects Annotated

Genes (Rattus norvegicus)
Cdx2  (caudal type homeo box 2)
Muc2  (mucin 2, oligomeric mucus/gel-forming)
Ptgs2  (prostaglandin-endoperoxide synthase 2)

Genes (Mus musculus)
Cdx2  (caudal type homeobox 2)
Muc2  (mucin 2)
Ptgs2  (prostaglandin-endoperoxide synthase 2)

Genes (Homo sapiens)
CDX2  (caudal type homeobox 2)
MUC2  (mucin 2, oligomeric mucus/gel-forming)
PTGS2  (prostaglandin-endoperoxide synthase 2)


Additional Information